Medexus Pharmaceuticals (MDP) Stock Chart & Stock Price History C$2.70 -0.07 (-2.53%) As of 10/17/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock Medexus Pharmaceuticals Stock Price Performance The Medexus Pharmaceuticals (MDP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 7.14%, with a year-to-date return of -21.97%. In the past month, the stock has decreased 7.85%, reflecting recent market activity. As of the latest close, Medexus Pharmaceuticals traded at C$2.70 with a market cap of C$87.10 million and volume of 22,824 shares. Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.37%1 Month Performance-7.85%3 Month Performance-3.91%Year-To-Date Performance-21.97%1 Year Performance+7.14% MDP Stock Chart for Saturday, October, 18, 2025 MDP Chart by TradingView Medexus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/17/2025C$2.77C$2.70-2.53%C$2.90C$2.6622,824 shsC$87.10 million10/16/2025C$2.79C$2.77-0.72%C$2.87C$2.7719,565 shsC$89.36 million10/15/2025C$2.79C$2.79C$2.83C$2.7814,814 shsC$90 million10/14/2025C$2.71C$2.79+2.95%C$2.83C$2.7023,571 shsC$90 million10/13/2025C$2.71C$2.71C$2.86C$2.7140,229 shsC$87.42 million10/10/2025C$2.85C$2.71-4.91%C$2.86C$2.7140,229 shsC$87.42 million10/09/2025C$2.92C$2.85-2.40%C$2.97C$2.8135,416 shsC$91.94 million10/08/2025C$2.84C$2.92+2.82%C$2.92C$2.8545,433 shsC$94.19 million10/07/2025C$2.80C$2.84+1.43%C$2.91C$2.7826,776 shsC$91.61 million10/06/2025C$2.86C$2.80-2.10%C$2.89C$2.7535,783 shsC$90.32 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/03/2025C$2.90C$2.86-1.38%C$2.95C$2.8644,204 shsC$92.26 million10/02/2025C$2.56C$2.90+13.28%C$2.93C$2.56179,937 shsC$93.55 million10/01/2025C$2.60C$2.56-1.54%C$2.65C$2.5550,700 shsC$82.58 million09/30/2025C$2.69C$2.60-3.35%C$2.70C$2.5960,523 shsC$83.87 million09/29/2025C$2.77C$2.69-2.89%C$2.82C$2.6978,544 shsC$86.77 million09/26/2025C$2.97C$2.77-6.73%C$2.95C$2.73161,358 shsC$89.36 million09/25/2025C$2.99C$2.97-0.67%C$3.00C$2.9382,716 shsC$95.81 million09/24/2025C$2.94C$2.99+1.70%C$3.01C$2.94100,933 shsC$96.45 million09/23/2025C$2.99C$2.94-1.67%C$3.06C$2.9267,385 shsC$96.45 million09/22/2025C$3.03C$2.99-1.32%C$3.05C$2.9438,112 shsC$96.45 million09/19/2025C$2.93C$3.03+3.41%C$3.08C$3.0019,804 shsC$97.74 million09/18/2025C$2.96C$2.93-1.01%C$3.02C$2.9316,881 shsC$94.52 million09/17/2025C$2.97C$2.96-0.34%C$3.01C$2.9516,833 shsC$95.48 million Related Companies Organigram Stock Chart SugarBud Craft Growers Stock Chart HLS Therapeutics Stock Chart BioSyent Stock Chart Cardiol Therapeutics Stock Chart Decibel Cannabis Stock Chart Charlotte's Web Stock Chart MediPharm Labs Stock Chart Willow Biosciences Stock Chart Voyageur Pharmaceuticals Stock Chart Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:MDP) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
